ArticleNPJ breast cancer2025

Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsies.

Yael Bar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.